34992373|t|QTc Interval Prolongation with Therapies Used to Treat Patients with Parkinson's Disease Psychosis: A Narrative Review.
34992373|a|In addition to the classic motor symptoms of Parkinson's disease (PD), people with PD frequently experience nonmotor symptoms that can include autonomic dysfunction and neuropsychiatric symptoms such as PD psychosis (PDP). Common patient characteristics, including older age, use of multiple medications, and arrhythmias, are associated with increased risk of corrected QT interval (QTc) prolongation, and treatments for PDP (antipsychotics, dementia medications) may further increase this risk. This review evaluates how medications used to treat PDP affect QTc interval from literature indexed in the PubMed and Embase databases. Although not indicated for the treatment of psychosis, dementia therapies such as donepezil, rivastigmine, memantine, and galantamine are often used with or without antipsychotics and have minimal effects on QTc interval. Among the antipsychotics, data suggesting clinically meaningful QTc interval prolongation are limited. However, many antipsychotics have other safety concerns. Aripiprazole, olanzapine, and risperidone negatively affect motor function and are not recommended for PDP. Quetiapine is often sedating, can exacerbate underlying neurogenic orthostatic hypotension, and may prolong the QTc interval. Pimavanserin was approved by the US Food and Drug Administration (FDA) in 2016 and remains the only FDA-approved medication available to treat hallucinations and delusions associated with PDP. However, pimavanserin can increase QTc interval by approximately 5-8 ms. The potential for QTc prolongation should be considered in patients with symptomatic cardiac arrhythmias and those receiving QT-prolonging medications. In choosing a medication to treat PDP, expected efficacy must be balanced with potential safety concerns for individual patients.
34992373	0	25	QTc Interval Prolongation	Disease	MESH:D008133
34992373	55	63	Patients	Species	9606
34992373	69	88	Parkinson's Disease	Disease	MESH:D010300
34992373	89	98	Psychosis	Disease	MESH:D011618
34992373	165	184	Parkinson's disease	Disease	MESH:D010300
34992373	186	188	PD	Disease	MESH:D010300
34992373	191	197	people	Species	9606
34992373	203	205	PD	Disease	MESH:D010300
34992373	263	284	autonomic dysfunction	Disease	MESH:D001342
34992373	289	314	neuropsychiatric symptoms	Disease	MESH:D001523
34992373	323	335	PD psychosis	Disease	MESH:D010300
34992373	337	340	PDP	Disease	MESH:D010300
34992373	350	357	patient	Species	9606
34992373	429	440	arrhythmias	Disease	MESH:D001145
34992373	490	520	QT interval (QTc) prolongation	Disease	MESH:D008133
34992373	541	544	PDP	Disease	MESH:D010300
34992373	562	570	dementia	Disease	MESH:D003704
34992373	668	671	PDP	Disease	MESH:D010300
34992373	796	805	psychosis	Disease	MESH:D011618
34992373	807	815	dementia	Disease	MESH:D003704
34992373	834	843	donepezil	Chemical	MESH:D000077265
34992373	845	857	rivastigmine	Chemical	MESH:D000068836
34992373	859	868	memantine	Chemical	MESH:D008559
34992373	874	885	galantamine	Chemical	MESH:D005702
34992373	1038	1063	QTc interval prolongation	Disease	MESH:D008133
34992373	1134	1146	Aripiprazole	Chemical	MESH:D000068180
34992373	1148	1158	olanzapine	Chemical	MESH:D000077152
34992373	1164	1175	risperidone	Chemical	MESH:D018967
34992373	1237	1240	PDP	Disease	MESH:D010300
34992373	1242	1252	Quetiapine	Chemical	MESH:D000069348
34992373	1298	1332	neurogenic orthostatic hypotension	Disease	MESH:D007024
34992373	1368	1380	Pimavanserin	Chemical	MESH:C510793
34992373	1511	1525	hallucinations	Disease	MESH:D006212
34992373	1530	1539	delusions	Disease	MESH:D063726
34992373	1556	1559	PDP	Disease	MESH:D010300
34992373	1570	1582	pimavanserin	Chemical	MESH:C510793
34992373	1652	1668	QTc prolongation	Disease	MESH:D008133
34992373	1693	1701	patients	Species	9606
34992373	1719	1738	cardiac arrhythmias	Disease	MESH:D001145
34992373	1759	1784	QT-prolonging medications	Chemical	-
34992373	1820	1823	PDP	Disease	MESH:D010300
34992373	1906	1914	patients	Species	9606
34992373	Negative_Correlation	MESH:D008559	MESH:D011618
34992373	Negative_Correlation	MESH:D000077265	MESH:D011618
34992373	Negative_Correlation	MESH:D005702	MESH:D011618
34992373	Negative_Correlation	MESH:C510793	MESH:D063726
34992373	Negative_Correlation	MESH:C510793	MESH:D010300
34992373	Positive_Correlation	MESH:D000069348	MESH:D007024
34992373	Negative_Correlation	MESH:D000077265	MESH:D010300
34992373	Negative_Correlation	MESH:D000077265	MESH:D003704
34992373	Negative_Correlation	MESH:C510793	MESH:D006212
34992373	Negative_Correlation	MESH:D018967	MESH:D010300
34992373	Negative_Correlation	MESH:D005702	MESH:D003704
34992373	Negative_Correlation	MESH:D000068180	MESH:D010300
34992373	Negative_Correlation	MESH:D005702	MESH:D010300
34992373	Negative_Correlation	MESH:D000077152	MESH:D010300
34992373	Negative_Correlation	MESH:D008559	MESH:D010300
34992373	Negative_Correlation	MESH:D000068836	MESH:D011618
34992373	Negative_Correlation	MESH:D000068836	MESH:D010300
34992373	Negative_Correlation	MESH:D008559	MESH:D003704
34992373	Negative_Correlation	MESH:D000068836	MESH:D003704

